At a glance
- Originator Kowa; Nonindustrial source
- Class Antiasthmatics
- Mechanism of Action Histamine H1 receptor antagonists; Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 03 Oct 2006 Discontinued - Preclinical for Asthma in Japan (unspecified route)
- 03 Oct 2006 Discontinued - Preclinical for Asthma in Netherlands (unspecified route)
- 19 Oct 1998 New profile